• Organizations: Iantrek Inc
Iantrek raises $42M for launch of uveoscleral pathway glaucoma tech
Products

Iantrek raises $42M for launch of uveoscleral pathway glaucoma tech

AlloFlo Uveo is a hardware-free, naturally-derived bio-tissue solution for lowering IOP in POAG patients; commercial launch planned for later this year. 
Iantrek reports favorable 2-year data on uveoscleral outflow technology for glaucoma
Research

Iantrek reports favorable 2-year data on uveoscleral outflow technology for glaucoma

New study details favorable safety profile of the CycloPen System as a bio-interventional platform for OAG patients undergoing combined cataract surgery.
Iantrek names former Trukera Medical leader as new CEO
Business

Iantrek names former Trukera Medical leader as new CEO

Adam Szaronos joins the biotechnology company as it plans a full commercial launch of two surgical glaucoma devices later this year.
New research investigates uveoscleral outflow technology for OAG
Research

New research investigates uveoscleral outflow technology for OAG

Real-world clinical evidence study evaluates IOP reduction following use of Iantrek’s CycloPen System during cataract surgery.